Medivir AB announces that a poster entitled ‘A triple combination of fostrox with immune checkpoint and kinase inhibition shows increased anti-tumor efficacy in vivo,’ will be presented at the American Association for Cancer Research Annual Meeting by Fredrik Öberg, CSO at Medivir.
